Pulse Biosciences, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Hayward, CA
PLSE chart
What traders are saying about $PLSE
Latest postsPulse Biosciences, Inc. news
- Pulse Biosciences (PLSE) On Thyroid Data And Losses Has An Undervalued Narrative
Simply Wall St ·
- Pulse Biosciences stock hits all-time high at 58.94 USD By Investing.com
Investing.com India ·
- Canaccord Genuity maintains Pulse Biosciences at Buy, raises price target to $74 from $58
TradingView ·
- Pulse Biosciences Inc (PLSE) Q3 2026 Earnings Call Highlights: NanoPulse AF Study Enrollment ...
Yahoo Finance ·
- Pulse Bio (PLSE) Q3 2026 Earnings Call Transcript
fool.com ·
- What Pulse Biosciences (PLSE) Said on Its Q3 Earnings Call
marketbeat.com ·
- Pulse Biosciences: 86% Achieve Thyroid Nodule Reduction Endpoint at Six Months
TradingView ·
- Pulse Biosciences, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Needham maintains Pulse Biosciences at Buy, raises price target to $64 from $58
TradingView ·
- Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting
Yahoo Finance ·
- Neck symptoms fully resolved in 82% of those reporting them; nodules shrank by at least half in 86% of patients at six months.
Stock Titan ·
- Mizuho raises Pulse Biosciences stock price target on trial progress
Investing.com ·
Pulse Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $350,000 | $0 | $0 | $700,000 |
| Net income | -$72.8M | -$53.6M | -$42.2M | -$58.5M |
| Total assets (year end) | $94.5M | $132.5M | $59.2M | $77.9M |
| Cash and equivalents (year end) | $80.7M | $118.0M | $44.4M | $61.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Pulse Biosciences, Inc.
- Ticker
- PLSE (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Hayward, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1625101
- Former names
- Electroblate, Inc.
Frequently asked questions
What exchange is Pulse Biosciences, Inc. listed on?
Pulse Biosciences, Inc. trades on the Nasdaq under the ticker symbol PLSE.
What industry is Pulse Biosciences, Inc. in?
Pulse Biosciences, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Pulse Biosciences, Inc. headquartered?
Pulse Biosciences, Inc.'s business address on file with the SEC is in Hayward, CA.
When does Pulse Biosciences, Inc.'s fiscal year end?
Pulse Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Pulse Biosciences, Inc. report?
Pulse Biosciences, Inc. reported $350,000 in revenue for calendar year 2025, according to its SEC filings.